Aspaveli Evrópusambandið - íslenska - EMA (European Medicines Agency)

aspaveli

swedish orphan biovitrum ab (publ) - pegcetacoplan - blóðrauði, ofsakláði - Ónæmisbælandi lyf - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.

Lunsumio Evrópusambandið - íslenska - EMA (European Medicines Agency)

lunsumio

roche registration gmbh - mosunetuzumab - eitilæxli, follicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Carvykti Evrópusambandið - íslenska - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - mergæxli - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Kimmtrak Evrópusambandið - íslenska - EMA (European Medicines Agency)

kimmtrak

immunocore ireland limited - tebentafusp - uveal neoplasms - Æxlishemjandi lyf - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Roctavian Evrópusambandið - íslenska - EMA (European Medicines Agency)

roctavian

biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).

Thalidomide Lipomed Evrópusambandið - íslenska - EMA (European Medicines Agency)

thalidomide lipomed

lipomed gmbh - dauða - mergæxli - Ónæmisbælandi lyf - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Stilnoct Filmuhúðuð tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

stilnoct filmuhúðuð tafla 10 mg

sanofi-aventis norge as - zolpidemum tartrat - filmuhúðuð tafla - 10 mg

Vinorelbine Alvogen Mjúkt hylki 30 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vinorelbine alvogen mjúkt hylki 30 mg

alvogen pharma trading europe eood - vinorelbinum tvítartrat - mjúkt hylki - 30 mg